FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Saphris (asenapine) by Allergan to update its labeling, potentially reflecting an expanded or clarified use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder Manic or Mixed Episodes
• Schizophrenia

Drugs mentioned

• Saphris (asenapine)

Snippet

SUPPL AP for SAPHRIS (ASENAPINE MALEATE)